Provisional timeline for future data releases
The tables below gives details of upcoming data releases and estimated dates for when each release will take place. For details about the most recent data release and past releases see here.
Please be aware that due to the current COVID-19 pandemic UK Biobank's priorities for future data availability are under constant review and timelines are subject to change.
Regular Data Portal updates
|Type of data||About||Approximate frequency|
|Death Data||Death registry data for England, Scotland & Wales on the Data Portal.||Usually monthly, but currently on hold.|
|Hospital Inpatient Data||Hospital inpatient data for England & Scotland on the Data Portal.||Usually monthly, but currently on hold.|
|Covid-19 Test Result Data||Covid-19 test result data for England, Scotland & Wales on the Data Portal||Monthly|
|GP Data||Further primary care (GP) data from TPP & EMIS on the Data Portal. |
This data is available to be used for COVID-19 research only.
Note that updates to the EMIS and TPP GP tables will not generally happen simultaneously. The same is true for Covid-19 test results, which are received from different data providers for England, Scotland & Wales. The date that each table on the Data Portal was last updated can be found at the bottom of the timelines page.
Planned future releases
|Type of data||About||Approximate release date|
|Exome data||Release of next tranche of exome data (for 300k exomes)||September 2021|
|Genome data||Release of first tranche of whole genome data (for 200 genomes)||Late 2021|
|SARS-CoV-2 antibody data||SARS-CoV-2 antibody status data||January 2022|
|Algorithmically-defined outcome fields||The Algorithmically-defined Outcomes (Category 42) will be updated to account for the new death and inpatient data. Some simplification of the way that algorithms operate will also take place.||January 2022|
|SARS-CoV-2 serology data||SARS-CoV-2 antibody status data for 20,000 individuals (10,000 UK Biobank participants & 10,000 of their adult children/grandchildren) over a six-month period, June-Nov 2020.||Early 2022|
|Residential location data||An update to the residential location of participants.||Early 2022|
|Enhanced cancer data||Cancer stage and grade. Data on cancer treatment including radiotherapy, chemotherapy cycles and surgery.||2022|
|Hospital inpatient data||As well as continuing rolling updates to the English & Scottish inpatient data, we plan an update to the Welsh data to cover the period since February 2018.||2022|
|Additional Scottish hospital inpatient data||Scottish maternity and psychiatric data||2022|